As previously reported, the occurrence and progression of cancers includes both genetic and epigenetic alterations [39,40], and for epigenetic alterations, ID4 gene methylation could be used for auxiliary diagnosis and prognosis of MDS patients without significant genetic alterations. Here, ID4 is linked to myelodysplastic syndrome.